A forum representing the Indian biotechnology sector has inked a memorandum of understanding (MoU) with Japan’s Forum for Innovative Regenerative Medicine (FIRM) to accelerate research on regenerative medicine.
The partnership between the Association of Biotechnology Led Enterprises (ABLE) and FIRM is a unique platform to advance and promote commercialisation of life-saving products in regenerative medicine in both the countries.
The collaborative programmes between ABLE and FIRM will focus on advancing the individual and common missions by sharing information including technology, policy, partnerships and opportunities such as co-sponsoring meetings and other cooperation based on common concern. The MoU was signed by P. Manohar, Head of the Committee for Regenerative Medicine Group of ABLE and FIRM chairman Yuzo Toda.
Title
Research on regenerative medicine
VATIS UPDATE Part
Article body
Source